| Detected | Trial | Change |
|---|---|---|
| 2026-05-19 | NCT06998524 A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von… |
date change Primary completion pushed: 2027-03-30 -> 2027-04-30 |
| 2026-05-19 | NCT06998524 A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von… |
date change Completion pushed: 2029-03-30 -> 2029-04-30 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06145373 | A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe… | Hemophilia A | Recruiting |
| NCT05181618 | A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants… | Severe Hemophilia A | Active, Not Recruiting |
| Phase 3 | |||
| NCT04563520 | SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis | Hemophilia A | Recruiting |
| NCT06998524 | A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von… | Von Willebrand Disease, Type 3 | Recruiting |
| NCT07416604 | A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in… | Hemophilia A | Recruiting |
| NCT04431726 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of… | Severe Hemophilia A | Active, Not Recruiting |
| Phase 1 | |||
| NCT05500807 | Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A | Von Willebrand Disease, Type 3 | Recruiting |
| Not specified | |||
| NCT05022459 | Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports… | Hemophilia A | Recruiting |